BMP signalling in skeletal development, disease and repair

Nature Reviews Endocrinology

Volumn 12, Issue 4, 2016, Pages 203-221

  Salazar, Valerie S ^a   Gamer, Laura W ^a   Rosen, Vicki ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; LIGAND; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; OSTEOGENIC PROTEIN 1;

BONE DEVELOPMENT; BONE DISEASE; BONE REMODELING; DEVELOPMENTAL GENETICS; HISTORY OF MEDICINE; HUMAN; JOINT; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BONE; BONE REGENERATION; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE DISEASES; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; GENE EXPRESSION REGULATION; HUMANS; SIGNAL TRANSDUCTION;

EID: 84961215919     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2016.12     Document Type: Review

References (227)

1. Urist, M. R. & Strates, B. S. Bone morphogenetic protein. J. Dent. Res. 50, 1392-1406 (1971
2. Nogami, H. & Urist, M. R. A morphogenetic matrix for differentiation of cartilage in tissue culture. Proc. Soc. Exp. Biol. Med. 134, 530-535 (1970
3. Urist, M. R. Bone: formation by autoinduction. 1965. Clin. Orthop. Relat. Res. 395, 4-10 (2002). Reference 3 shows that post-fetal osteogenesis can be induced in live animals by acelluar decalcified bone fragments and demonstrates the presence of osteoinductive factors in the bone extracellular matrix
4. Wozney, J. M., et al. Novel regulators of bone formation: molecular clones and activities. Science 242, 1528-1534 (1988
5. Lo, K. W., Ulery, B. D., Ashe, K. M. & Laurencin, C. T. Studies of bone morphogenetic protein-based surgical repair. Adv. Drug Deliv. Rev. 64, 1277-1291 (2012
6. Shore, E. M., et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet. 38, 525-527 (2006
7. Mizuguchi, T., et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat. Genet. 36, 855-860 (2004
8. Loeys, B. L., et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37, 275-281 (2005
9. Van Der Kraan, P. M., Blaney Davidson, E. N. & Van den Berg, W. B. Bone morphogenetic proteins and articular cartilage: to serve and protect or a wolf in sheep clothing's?. Osteoarthritis Cartilage 18, 735-741 (2010
10. Van Der Kraan, P. M., Blaney Davidson, E. N. & Van den Berg, W. B. A role for age-related changes in TGFβ signaling in aberrant chondrocyte differentiation and osteoarthritis. Arthritis Res. Ther. 12, 201 (2010
11. Johnson, A. B. Operative Therapeusis Vol. 2 Ch. 7 (D. Appleton & Company, 1915
12. Huggins, C., Wiseman, S. & Reddi, A. H. Transformation of fibroblasts by allogeneic and xenogeneic transplants of demineralized tooth and bone. J. Exp. Med. 132, 1250-1258 (1970
13. Sampath, T. K. & Reddi, A. H. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc. Natl Acad. Sci. USA 78, 7599-7603 (1981
14. Sampath, T. K., Muthukumaran, N. & Reddi, A. H. Isolation of osteogenin, an extracellular matrix-Associated, bone-inductive protein, by heparin affinity chromatography. Proc. Natl Acad. Sci. USA 84, 7109-7113 (1987
15. Rosen, V. BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev. 20, 475-480 (2009
16. Huminiecki, L., et al. Emergence, development and diversification of the TGF β signalling pathway within the animal kingdom. BMC Evol. Biol. 9, 28 (2009
17. Tuazon, F. B. & Mullins, M. C. Temporally coordinated signals progressively pattern the anteroposterior and dorsoventral body axes. Semin. Cell Dev. Biol. 42, 118-133 (2015
18. Kahlem, P. & Newfeld, S. J. Informatics approaches to understanding TGFβ pathway regulation. Development 136, 3729-3740 (2009
19. Dereeper, A., et al. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 36, W465-W469 (2008
20. Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792-1797 (2004
21. Schmierer, B. & Hill, C. S. TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell. Biol. 8, 970-982 (2007).
22. Hinck, A. P. Structural studies of the TGF βs and their receptors - insights into evolution of the TGF β superfamily. FEBS Lett. 586, 1860-1870 (2012
23. Sampath, T. K., Rashka, K. E., Doctor, J. S., Tucker, R. F. & Hoffmann, F. M. Drosophila transforming growth factor β superfamily proteins induce endochondral bone formation in mammals. Proc. Natl Acad. Sci. USA 90, 6004-6008 (1993
24. Mu, Y., Gudey, S. K. & Landstrom, M. Non-Smad signaling pathways. Cell Tissue Res. 347, 11-20 (2012
25. Ross, S., et al. Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription. EMBO J. 25, 4490-4502 (2006
26. Xi, Q., et al. A poised chromatin platform for TGF β access to master regulators. Cell 147, 1511-1524 (2011
27. Mullen, A. C., et al. Master transcription factors determine cell-type-specific responses to TGF β signaling. Cell 147, 565-576 (2011
28. Trompouki, E., et al. Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell 147, 577-589 (2011
29. Ling, N., et al. Pituitary FSH is released by a heterodimer of the β subunits from the two forms of inhibin. Nature 321, 779-782 (1986
30. Sporn, M. B. & Todaro, G. J. Autocrine secretion and malignant transformation of cells. N. Engl. J. Med. 303, 878-880 (1980
31. Sun, P. D. & Davies, D. R. The cystine-knot growth-factor superfamily. Annu. Rev. Biophys. Biomol. Struct. 24, 269-291 (1995
32. Gray, A. M. & Mason, A. J. Requirement for activin A and transforming growth factor β1 pro-regions in homodimer assembly. Science 247, 1328-1330 (1990
33. Ben-Haim, N., et al. The nodal precursor acting via activin receptors induces mesoderm by maintaining a source of its convertases and BMP4. Dev. Cell 11, 313-323 (2006
34. Shimmi, O., Umulis, D., Othmer, H. & O'Connor, M. B. Facilitated transport of a Dpp/Scw heterodimer by Sog/Tsg leads to robust patterning of the Drosophila blastoderm embryo. Cell 120, 873-886 (2005
35. Egerman, M. A., et al. GDF11 increases with age and inhibits skeletal muscle regeneration. Cell Metab. 22, 164-174 (2015
36. Loffredo, F. S., et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153, 828-839 (2013
37. Smith, S. C., et al. GDF11 does not rescue aging-related pathological hypertrophy. Circ. Res. 117, 926-932 (2015
38. David, L., et al. Bone morphogenetic protein 9 is a circulating vascular quiescence factor. Circ. Res. 102, 914-922 (2008
39. Sinha, M., et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 344, 649-652 (2014
40. Greenwald, J., et al. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell 11, 605-617 (2003
41. Groppe, J., et al. Cooperative assembly of TGF β superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol. Cell 29, 157-168 (2008
42. Lowery, J. W., et al. Loss of BMPR2 leads to high bone mass due to increased osteoblast activity. J. Cell Sci. 128, 1308-1315 (2015
43. Huse, M., et al. The TGF β receptor activation process: an inhibitor- to substrate-binding switch. Mol. Cell 8, 671-682 (2001
44. Newfeld, S. J., Chartoff, E. H., Graff, J. M., Melton, D. A. & Gelbart, W. M. Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF β responsive cells. Development 122, 2099-2108 (1996
45. Zawel, L., et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617 (1998
46. Shi, Y., et al. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF β signaling. Cell 94, 585-594 (1998
47. Xiao, Z., Liu, X., Henis, Y. I. & Lodish, H. F. A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation. Proc. Natl Acad. Sci. USA 97, 7853-7858 (2000
48. Kim, J., Johnson, K., Chen, H. J., Carroll, S. & Laughon, A. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388, 304-308 (1997
49. Lo, R. S., Chen, Y. G., Shi, Y., Pavletich, N. P. & Massague, J. The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF β receptors. EMBO J. 17, 996-1005 (1998
50. Kretzschmar, M., Doody, J. & Massague, J. Opposing BMP and EGF signalling pathways converge on the TGF β family mediator Smad1. Nature 389, 618-622 (1997
51. Fuentealba, L. C., et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/ Smad1 signal. Cell 131, 980-993 (2007
52. Sapkota, G., Alarcon, C., Spagnoli, F. M., Brivanlou, A. H. & Massague, J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell 25, 441-454 (2007
53. Lagna, G., Hata, A., Hemmati-Brivanlou, A. & Massague, J. Partnership between DPC4 and SMAD proteins in TGF β signalling pathways. Nature 383, 832-836 (1996
54. Moustakas, A. & Heldin, C. H. The regulation of TGFβ signal transduction. Development 136, 3699-3714 (2009
55. Hatsell, S. J., et al. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Sci. Transl Med. 7, 303ra137 (2015
56. Brazil, D. P., Church, R. H., Surae, S., Godson, C. & Martin, F. BMP signalling: agony and antagony in the family. Trends Cell Biol. 25, 249-264 (2015
57. Itoh, S. & ten Dijke, P. Negative regulation of TGF β receptor/Smad signal transduction. Curr. Opin. Cell Biol. 19, 176-184 (2007
58. Brunet, L. J., McMahon, J. A., McMahon, A. P. & Harland, R. M. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280, 1455-1457 (1998
59. Stafford, D. A., Brunet, L. J., Khokha, M. K., Economides, A. N. & Harland, R. M. Cooperative activity of noggin and gremlin 1 in axial skeleton development. Development 138, 1005-1014 (2011
60. Inoue, S., et al. Localization of follistatin, an activin-binding protein, in bone tissues. Calcif. Tissue Int. 55, 395-397 (1994
61. Balemans, W. & Van Hul, W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev. Biol. 250, 231-250 (2002
62. Thompson, T. B., Lerch, T. F., Cook, R. W., Woodruff, T. K. & Jardetzky, T. S. The structure of the follistatin: activin complex reveals antagonism of both type I and type II receptor binding. Dev. Cell 9, 535-543 (2005
63. Ge, G., Hopkins, D. R., Ho, W. B. & Greenspan, D. S. GDF11 forms a bone morphogenetic protein 1 activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. Mol. Cell. Biol. 25, 5846-5858 (2005
64. Kokabu, S., et al. BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol. Endocrinol. 26, 87-94 (2012
65. Sakuma, R., et al. Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion. Genes Cells 7, 401-412 (2002
66. Hayashi, H., et al. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89, 1165-1173 (1997
67. Imamura, T., et al. Smad6 inhibits signalling by the TGF β superfamily. Nature 389, 622-626 (1997
68. Nakao, A., et al. Identification of Smad7, a TGFβ- inducible antagonist of TGF β signalling. Nature 389, 631-635 (1997
69. Murakami, G., Watabe, T., Takaoka, K., Miyazono, K. & Imamura, T. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol. Biol. Cell 14, 2809-2817 (2003
70. Inoue, Y. & Imamura, T. Regulation of TGF β family signaling by E3 ubiquitin ligases. Cancer Sci. 99, 2107-2112 (2008
71. Tsukamoto, S., et al. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling. Sci. Rep. 4, 7596 (2014
72. Massague, J. TGFβ signalling in context. Nat. Rev. Mol. Cell. Biol. 13, 616-630 (2012
73. Long, F. & Ornitz, D. M. Development of the endochondral skeleton. Cold Spring Harb. Perspect. Biol. 5, a008334 (2013
74. Zeller, R., Lopez-Rios, J. & Zuniga, A. Vertebrate limb bud development: moving towards integrative analysis of organogenesis. Nat. Rev. Genet. 10, 845-858 (2009
75. Logan, M., et al. Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 33, 77-80 (2002
76. Zhang, H. & Bradley, A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122, 2977-2986 (1996
77. Ovchinnikov, D. A., et al. BMP receptor type IA in limb bud mesenchyme regulates distal outgrowth and patterning. Dev. Biol. 295, 103-115 (2006
78. Lim, J., et al. BMP-Smad4 signaling is required for precartilaginous mesenchymal condensation independent of Sox9 in the mouse. Dev. Biol. 400, 132-138 (2015
79. Benazet, J. D., et al. Smad4 is required to induce digit ray primordia and to initiate the aggregation and differentiation of chondrogenic progenitors in mouse limb buds. Development 139, 4250-4260 (2012
80. Bandyopadhyay, A., et al. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet. 2, e216 (2006
81. Tsuji, K., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 38, 1424-1429 (2006
82. Tsuji, K., et al. BMP4 is dispensable for skeletogenesis and fracture-healing in the limb. J. Bone Joint Surg. Am. 90 (Suppl. 1), 14-18 (2008
83. Tsuji, K., et al. Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair. J. Orthop. Res. 28, 384-389 (2010
84. Settle, S. H. Jr et al. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev. Biol. 254, 116-130 (2003
85. Storm, E. E. & Kingsley, D. M. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 122, 3969-3979 (1996
86. Pignatti, E., Zeller, R. & Zuniga, A. To BMP or not to BMP during vertebrate limb bud development. Semin. Cell Dev. Biol. 32, 119-127 (2014
87. Sun, X., et al. Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development. Nat. Genet. 25, 83-86 (2000
88. Choi, K. S., Lee, C., Maatouk, D. M. & Harfe, B. D. Bmp2, Bmp4 and Bmp7 are co required in the mouse AER for normal digit patterning but not limb outgrowth. PLoS ONE 7, e37826 (2012
89. Norrie, J. L., et al. Dynamics of BMP signaling in limb bud mesenchyme and polydactyly. Dev. Biol. 393, 270-281 (2014
90. Reddi, A. H. Cell biology and biochemistry of endochondral bone development. Coll. Relat. Res. 1, 209-226 (1981
91. Cancedda, R., Descalzi Cancedda, F. & Castagnola, P. Chondrocyte differentiation. Int. Rev. Cytol. 159, 265-358 (1995
92. Lanske, B., et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273, 663-666 (1996
93. Vortkamp, A., et al. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273, 613-622 (1996
94. Minina, E., Kreschel, C., Naski, M. C., Ornitz, D. M. & Vortkamp, A. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev. Cell 3, 439-449 (2002
95. Cooper, K. L., et al. Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions. Nature 495, 375-378 (2013
96. Galotto, M., et al. Hypertrophic chondrocytes undergo further differentiation to osteoblast-like cells and participate in the initial bone formation in developing chick embryo. J. Bone Miner. Res. 9, 1239-1249 (1994
97. Yang, G., et al. Osteogenic fate of hypertrophic chondrocytes. Cell Res. 24, 1266-1269 (2014
98. Yang, L., Tsang, K. Y., Tang, H. C., Chan, D. & Cheah, K. S. Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation. Proc. Natl Acad. Sci. USA 111, 12097-12102 (2014
99. Zhou, X., et al. Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice. PLoS Genet. 10, e1004820 (2014
100. Ono, N., Ono, W., Nagasawa, T. & Kronenberg, H. M. A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones. Nat. Cell Biol. 16, 1157-1167 (2014
101. Barna, M. & Niswander, L. Visualization of cartilage formation: insight into cellular properties of skeletal progenitors and chondrodysplasia syndromes. Dev. Cell 12, 931-941 (2007
102. Rigueur, D., et al. The type I BMP receptor ACVR1/ALK2 is required for chondrogenesis during development. J. Bone Miner. Res. 30, 733-741 (2015
103. Yoon, B. S., et al. Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc. Natl Acad. Sci. USA 102, 5062-5067 (2005
104. Zhang, J., et al. Smad4 is required for the normal organization of the cartilage growth plate. Dev. Biol. 284, 311-322 (2005
105. Retting, K. N., Song, B., Yoon, B. S. & Lyons, K. M. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 136, 1093-1104 (2009
106. Shu, B., et al. BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. J. Cell Sci. 124, 3428-3440 (2011
107. Merino, R., et al. Expression and function of Gdf 5 during digit skeletogenesis in the embryonic chick leg bud. Dev. Biol. 206, 33-45 (1999
108. Chang, S. C., et al. Cartilage-derived morphogenetic proteins. New members of the transforming growth factor β superfamily predominantly expressed in long bones during human embryonic development. J. Biol. Chem. 269, 28227-28234 (1994
109. Baur, S. T., Mai, J. J. & Dymecki, S. M. Combinatorial signaling through BMP receptor IB and GDF5: shaping of the distal mouse limb and the genetics of distal limb diversity. Development 127, 605-619 (2000
110. Storm, E. E., et al. Limb alterations in brachypodism mice due to mutations in a new member of the TGF β superfamily. Nature 368, 639-643 (1994
111. Seo, H. S. & Serra, R. Deletion of Tgfbr2 in Prx1 cre expressing mesenchyme results in defects in development of the long bones and joints. Dev. Biol. 310, 304-316 (2007
112. Longobardi, L., et al. TGF β type II receptor/MCP 5 axis: at the crossroad between joint and growth plate development. Dev. Cell 23, 71-81 (2012
113. Yang, W., et al. Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells. J. Cell Sci. 126, 4085-4098 (2013
114. Henry, S. P., et al. Generation of aggrecan CreERT2 knockin mice for inducible Cre activity in adult cartilage. Genesis 47, 805-814 (2009
115. Jing, J., et al. BMP receptor 1A determines the cell fate of the postnatal growth plate. Int. J. Biol. Sci. 9, 895-906 (2013
116. Rodda, S. J. & McMahon, A. P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133, 3231-3244 (2006
117. Dacquin, R., Starbuck, M., Schinke, T. & Karsenty, G. Mouse a1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev. Dyn. 224, 245-251 (2002
118. Liu, F., et al. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. Int. J. Dev. Biol. 48, 645-653 (2004
119. Maes, C., Kobayashi, T. & Kronenberg, H. M. A novel transgenic mouse model to study the osteoblast lineage in vivo. Ann. NY Acad. Sci. 1116, 149-164 (2007
120. Salazar, V. S., et al. Embryonic ablation of osteoblast Smad4 interrupts matrix synthesis in response to canonical Wnt signaling and causes an osteogenesis-imperfecta-like phenotype. J. Cell Sci. 126, 4974-4984 (2013
121. Tan, X., et al. Smad4 is required for maintaining normal murine postnatal bone homeostasis. J. Cell Sci. 120, 2162-2170 (2007
122. McBride, S. H., et al. Long bone structure and strength depend on BMP2 from osteoblasts and osteocytes, but not vascular endothelial cells. PLoS ONE 9, e96862 (2014
123. Feng, J., et al. Abnormalities in the enamel in Bmp2 deficient mice. Cells Tissues Organs 194, 216-221 (2011
124. Guo, F., et al. Bmp2 deletion causes an amelogenesis imperfecta phenotype via regulating enamel gene expression. J. Cell. Physiol. 230, 1871-1882 (2014
125. McBride-Gagyi, S. H., McKenzie, J. A., Buettmann, E. G., Gardner, M. J. & Silva, M. J. Bmp2 conditional knockout in osteoblasts and endothelial cells does not impair bone formation after injury or mechanical loading in adult mice. Bone 81, 533-543 (2015
126. Chappuis, V., et al. Periosteal BMP2 activity drives bone graft healing. Bone 51, 800-809 (2012
127. Mi, M., et al. Chondrocyte BMP2 signaling plays an essential role in bone fracture healing. Gene 512, 211-218 (2013
128. Sanchez-Duffhues, G., Hiepen, C., Knaus, P. & Ten Dijke, P. Bone morphogenetic protein signaling in bone homeostasis. Bone 80, 43-59 (2015
129. Mishina, Y., et al. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J. Biol. Chem. 279, 27560-27566 (2004
130. Ray, A., Singh, P. N., Sohaskey, M. L., Harland, R. M. & Bandyopadhyay, A. Precise spatial restriction of BMP signaling is essential for articular cartilage differentiation. Development 142, 1169-1179 (2015
131. Mitrovic, D. R. Development of the metatarsophalangeal joint of the chick embryo: morphological, ultrastructural and histochemical studies. Am. J. Anat. 150, 333-347 (1977
132. Wolfman, N. M., et al. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF β gene family. J. Clin. Invest. 100, 321-330 (1997
133. Li, T., et al. Joint TGF β type II receptor-expressing cells: ontogeny and characterization as joint progenitors. Stem Cells Dev. 22, 1342-1359 (2013
134. Spagnoli, A., et al. TGF β signaling is essential for joint morphogenesis. J. Cell Biol. 177, 1105-1117 (2007
135. Dyment, N. A., et al. Gdf5 progenitors give rise to fibrocartilage cells that mineralize via hedgehog signaling to form the zonal enthesis. Dev. Biol. 405, 96-107 (2015
136. Koyama, E., et al. A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis. Dev. Biol. 316, 62-73 (2008
137. Rountree, R. B., et al. BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biol. 2, e355 (2004
138. Zimmerman, L. B., De Jesus-Escobar, J. M. & Harland, R. M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86, 599-606 (1996
139. Nishitoh, H., et al. Identification of type I and type II serine/threonine kinase receptors for growth/ differentiation factor 5. J. Biol. Chem. 271, 21345-21352 (1996
140. Nickel, J., Kotzsch, A., Sebald, W. & Mueller, T. D. A single residue of GDF 5 defines binding specificity to BMP receptor IB. J. Mol. Biol. 349, 933-947 (2005
141. Kotzsch, A., Nickel, J., Sebald, W. & Mueller, T. D. Purification, crystallization and preliminary data analysis of ligand-receptor complexes of growth and differentiation factor 5 (GDF5) and BMP receptor IB (BRIB). Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65, 779-783 (2009
142. Gong, Y., et al. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat. Genet. 21, 302-304 (1999
143. Seemann, P., et al. Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN. PLoS Genet. 5, e1000747 (2009
144. Yi, S. E., Daluiski, A., Pederson, R., Rosen, V. & Lyons, K. M. The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 127, 621-630 (2000
145. Wu, L., et al. Human developmental chondrogenesis as a basis for engineering chondrocytes from pluripotent stem cells. Stem Cell Rep. 1, 575-589 (2013
146. Rosen, V., et al. Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J. Bone Miner. Res. 9, 1759-1768 (1994
147. Larsson, J., et al. Abnormal angiogenesis but intact hematopoietic potential in TGF β type I receptor-deficient mice. EMBO J. 20, 1663-1673 (2001
148. Oshima, M., Oshima, H. & Taketo, M. M. TGF β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179, 297-302 (1996
149. Baffi, M. O., et al. Conditional deletion of the TGF β type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bones. Dev. Biol. 276, 124-142 (2004
150. Eyal, S., et al. On the development of the patella. Development 142, 1831-1839 (2015
151. Rasmussen, S. A., et al. Epidemiology of osteochondrodysplasias: changing trends due to advances in prenatal diagnosis. Am. J. Med. Genet. 61, 49-58 (1996
152. Weldner, B. M., Persson, P. H. & Ivarsson, S. A. Prenatal diagnosis of dwarfism by ultrasound screening. Arch. Dis. Child. 60, 1070-1072 (1985
153. Bonafe, L., et al. Nosology and classification of genetic skeletal disorders: 2015 revision. Am. J. Med. Genet. A 167A, 2869-2892 (2015
154. MacCarrick, G., et al. Loeys-Dietz syndrome: a primer for diagnosis and management. Genet. Med. 16, 576-587 (2014
155. Regalado, E. S., et al. Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circ. Res. 109, 680-686 (2011
156. Kinoshita, A., et al. Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat. Genet. 26, 19-20 (2000
157. Ghadami, M., et al. Genetic mapping of the Camurati- Engelmann disease locus to chromosome 19q13.1- q13.3. Am. J. Hum. Genet. 66, 143-147 (2000
158. Campos-Xavier, B., et al. Phenotypic variability at the TGF â1 locus in Camurati-Engelmann disease. Hum. Genet. 109, 653-658 (2001
159. Waning, D. L., et al. Excess TGF β mediates muscle weakness associated with bone metastases in mice. Nat. Med. 21, 1262-1271 (2015
160. Smaldone, S., et al. Fibrillin 1 regulates skeletal stem cell differentiation by modulating TGFβ activity within the marrow niche. J. Bone Miner. Res. 31, 86-97 (2015
161. Grafe, I., et al. Excessive transforming growth factor β signaling is a common mechanism in osteogenesis imperfecta. Nat. Med. 20, 670-675 (2014
162. Hellmann, T. V., Nickel, J. & Mueller, T. D. in Mutations in Human Genetic Disease (eds Cooper, D. N. & Chen, J. M.) 11-54 (Intech Publishing, 2012
163. Douzgou, S., Lehmann, K., Mingarelli, R., Mundlos, S. & Dallapiccola, B. Compound heterozygosity for GDF5 in Du Pan type chondrodysplasia. Am. J. Med. Genet. A 146A, 2116-2121 (2008
164. Faiyaz-Ul Haque, M., et al. Mutation in the cartilage-derived morphogenetic protein 1 (CDMP1) gene in a kindred affected with fibular hypoplasia and complex brachydactyly (DuPan syndrome). Clin. Genet. 61, 454-458 (2002
165. Du Pan, C. M. Absence congenitale du perone sans deformation du tibia: curieuses deformations congenitales des mains. Revue d'Orthopedie 11, 227-234 (in French) (1924
166. Grebe, H. Chondrodysplasia; Monographie (Edizioni dell'Istituto Gregorio Mendel, 1955
167. Hunter, A. G. & Thompson, M. W. Acromesomelic dwarfism: description of a patient and comparison with previously reported cases. Hum. Genet. 34, 107-113 (1976
168. Thomas, J. T., et al. A human chondrodysplasia due to a mutation in a TGF β superfamily member. Nat. Genet. 12, 315-317 (1996
169. Thomas, J. T., et al. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat. Genet. 17, 58-64 (1997
170. Graul-Neumann, L. M., et al. Homozygous missense and nonsense mutations in BMPR1B cause acromesomelic chondrodysplasia-type Grebe. Eur. J. Hum. Genet. 22, 726-733 (2014
171. Costa, T., et al. Grebe syndrome: clinical and radiographic findings in affected individuals and heterozygous carriers. Am. J. Med. Genet. 75, 523-529 (1998
172. Demirhan, O., et al. A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies. J. Med. Genet. 42, 314-317 (2005
173. Seemann, P., et al. Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J. Clin. Invest. 115, 2373-2381 (2005
174. Lehmann, K., et al. Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2. Proc. Natl Acad. Sci. USA 100, 12277-12282 (2003
175. Kjaer, K. W., et al. A mutation in the receptor binding site of GDF5 causes Mohr-Wriedt brachydactyly type A2. J. Med. Genet. 43, 225-231 (2006
176. Robin, N. H., Gunay-Aygun, M., Polinkovsky, A., Warman, M. L. & Morrison, S. Clinical and locus heterogeneity in brachydactyly type C. Am. J. Med. Genet. 68, 369-377 (1997
177. Polinkovsky, A., et al. Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat. Genet. 17, 18-19 (1997
178. Polymeropoulos, M. H., Ide, S. E., Magyari, T. & Francomano, C. A. Brachydactyly type C gene maps to human chromsome 12q24. Genomics 38, 45-50 (1996
179. Savarirayan, R., et al. Broad phenotypic spectrum caused by an identical heterozygous CDMP 1 mutation in three unrelated families. Am. J. Med. Genet. A 117A, 136-142 (2003
180. Le Goff, C., Michot, C. & Cormier-Daire, V. Myhre syndrome. Clin. Genet. 85, 503-513 (2014
181. Starr, L. J., et al. Myhre syndrome: clinical features and restrictive cardiopulmonary complications. Am. J. Med. Genet. A 167A, 2893-2901 (2015
182. Le Goff, C., et al. Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. Nat. Genet. 44, 85-88 (2012
183. Minina, E., et al. BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 128, 4523-4534 (2001
184. Freire-Maia, N., Maia, N. A. & Pacheco, C. N. Mohr- Wriedt (A2) brachydactyly: analysis of a large Brazilian kindred. Hum. Hered. 30, 225-231 (1980
185. Dathe, K., et al. Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2. Am. J. Hum. Genet. 84, 483-492 (2009
186. Lehmann, K., et al. A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. Am. J. Hum. Genet. 81, 388-396 (2007
187. Pang, X., et al. A novel missense mutation of NOG interferes with the dimerization of NOG and causes proximal symphalangism syndrome in a Chinese family. Ann. Otol. Rhinol. Laryngol. 124, 745-751 (2015
188. Masuda, S., et al. A mutation in the heparin-binding site of noggin as a novel mechanism of proximal symphalangism and conductive hearing loss. Biochem. Biophys. Res. Commun. 447, 496-502 (2014
189. Takahashi, T., et al. Mutations of the NOG gene in individuals with proximal symphalangism and multiple synostosis syndrome. Clin. Genet. 60, 447-451 (2001
190. Brown, D. J., et al. Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. Am. J. Hum. Genet. 71, 618-624 (2002).
191. Dawson, K., et al. GDF5 is a second locus for multiple-synostosis syndrome. Am. J. Hum. Genet. 78, 708-712 (2006
192. Ye, M., et al. Mutation of the bone morphogenetic protein GDF3 causes ocular and skeletal anomalies. Hum. Mol. Genet. 19, 287-298 (2010
193. Levine, A. J., Levine, Z. J. & Brivanlou, A. H. GDF3 is a BMP inhibitor that can activate Nodal signaling only at very high doses. Dev. Biol. 325, 43-48 (2009
194. Huning, I. & Gillessen-Kaesbach, G. Fibrodysplasia ossificans progressiva: clinical course, genetic mutations and genotype-phenotype correlation. Mol. Syndromol. 5, 201-211 (2014
195. Kaplan, F. S., et al. Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J. Bone Joint Surg. Am. 92, 686-691 (2010
196. Zhou, X., et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531-543 (2010
197. Rajkovic, Z. & Krklec, V. The oldest treated bone fracture in Croatia - 130, 000 years ago [Croatian]. Acta Med. Croat. 62, 89-92 (2008
198. Erfan Zaki, M. Success of long bone fracture healing in ancient Egypt: a paleoepidemiological study of the Giza Necropolis skeletons. Acta Med. Hist. Adriat. 11, 275-284 (2013
199. Hippocrates. On Fractures (ReadHowYouWant.com, 2007
200. Redfern, R. A regional examination of surgery and fracture treatment in Iron Age and Roman Britain. Int. J. Osteoarchaeol. 20, 443-471 (2010
201. Anne, J., et al. Synchrotron imaging reveals bone healing and remodelling strategies in extinct and extant vertebrates. J. R. Soc. Interface 11, 20140277 (2014
202. Gautschi, O. P., Frey, S. P. & Zellweger, R. Bone morphogenetic proteins in clinical applications. ANZ J. Surg. 77, 626-631 (2007
203. Ali, I. H. & Brazil, D. P. Bone morphogenetic proteins and their antagonists: current and emerging clinical uses. Br. J. Pharmacol. 171, 3620-3632 (2014
204. Wheeler, D. L. & Enneking, W. F. Allograft bone decreases in strength in vivo over time. Clin. Orthop. Relat. Res. 435, 36-42 (2005
205. Colnot, C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J. Bone Miner. Res. 24, 274-282 (2009
206. Tiyapatanaputi, P., et al. A novel murine segmental femoral graft model. J. Orthop. Res. 22, 1254-1260 (2004
207. Zhang, X., Awad, H. A., O'Keefe, R. J., Guldberg, R. E. & Schwarz, E. M. A perspective: engineering periosteum for structural bone graft healing. Clin. Orthop. Relat. Res. 466, 1777-1787 (2008
208. Wang, Q., Huang, C., Xue, M. & Zhang, X. Expression of endogenous BMP 2 in periosteal progenitor cells is essential for bone healing. Bone 48, 524-532 (2011
209. Burkus, J. K., Sandhu, H. S., Gornet, M. F. & Longley, M. C. Use of rhBMP 2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J. Bone Joint Surg. Am. 87, 1205-1212 (2005
210. Glassman, S. D., et al. Initial fusion rates with recombinant human bone morphogenetic protein 2/ compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion. Spine (Phila Pa 1976) 30, 1694-1698 (2005
211. Burkus, J. K., Heim, S. E., Gornet, M. F. & Zdeblick, T. A. The effectiveness of rhBMP 2 in replacing autograft: an integrated analysis of three human spine studies. Orthopedics 27, 723-728 (2004
212. Cahill, K. S., McCormick, P. C. & Levi, A. D. A comprehensive assessment of the risk of bone morphogenetic protein use in spinal fusion surgery and postoperative cancer diagnosis. J. Neurosurg. Spine 23, 86-93 (2015
213. Sayama, C., et al. Routine use of recombinant human bone morphogenetic protein 2 in posterior fusions of the pediatric spine and incidence of cancer. J. Neurosurg. Pediatr. 16, 4-13 (2015
214. Murphy, L., et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 59, 1207-1213 (2008
215. Yelin, E., et al. Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997. Arthritis Rheum. 56, 1397-1407 (2007
216. Pazin, D. E., Gamer, L. W., Cox, K. A. & Rosen, V. Molecular profiling of synovial joints: use of microarray analysis to identify factors that direct the development of the knee and elbow. Dev. Dyn. 241, 1816-1826 (2012
217. Craft, A. M., et al. Generation of articular chondrocytes from human pluripotent stem cells. Nat. Biotechnol. 33, 638-645 (2015
218. Craft, A. M., et al. Specification of chondrocytes and cartilage tissues from embryonic stem cells. Development 140, 2597-2610 (2013
219. Monteiro, R. M., De Sousa Lopes, S. M., Korchynskyi, O., ten Dijke, P. & Mummery, C. L. Spatio-temporal activation of Smad1 and Smad5 in vivo: monitoring transcriptional activity of Smad proteins. J. Cell Sci. 117, 4653-4663 (2004
220. Abula, K., et al. Elimination of BMP7 from the developing limb mesenchyme leads to articular cartilage degeneration and synovial inflammation with increased age. FEBS Lett. 589, 1240-1248 (2015
221. Sanna, S., et al. Common variants in the GDF5-UQCC region are associated with variation in human height. Nat. Genet. 40, 198-203 (2008
222. Reynard, L. N. & Loughlin, J. Genetics and epigenetics of osteoarthritis. Maturitas 71, 200-204 (2012
223. Reynard, L. N., Bui, C., Canty-Laird, E. G., Young, D. A. & Loughlin, J. Expression of the osteoarthritis-Associated gene GDF5 is modulated epigenetically by DNA methylation. Hum. Mol. Genet. 20, 3450-3460 (2011
224. Sartori, R., et al. BMP signaling controls muscle mass. Nat. Genet. 45, 1309-1318 (2013
225. McPherron, A. C., Lawler, A. M. & Lee, S. J. Regulation of skeletal muscle mass in mice by a new TGF β superfamily member. Nature 387, 83-90 (1997
226. Chen, J. L., et al. Elevated expression of activins promotes muscle wasting and cachexia. FASEB J. 28, 1711-1723 (2014
227. Klammert, U., et al. GDF 5 can act as a context-dependent BMP 2 antagonist. BMC Biol. 13, 77 (2015